AU3577589A – Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
– Google Patents
AU3577589A – Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
– Google Patents
Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
Info
Publication number
AU3577589A
AU3577589A
AU35775/89A
AU3577589A
AU3577589A
AU 3577589 A
AU3577589 A
AU 3577589A
AU 35775/89 A
AU35775/89 A
AU 35775/89A
AU 3577589 A
AU3577589 A
AU 3577589A
AU 3577589 A
AU3577589 A
AU 3577589A
Authority
AU
Australia
Prior art keywords
proteinaceous
polypeptide components
medicaments
analogues
compositions
Prior art date
1989-04-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU35775/89A
Other versions
AU640611B2
(en
Inventor
Allen W. Benton
Henning Lowenstein
Lorraine M. Mulfinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vespa Laboratories Inc
Original Assignee
Vespa Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1989-04-13
Filing date
1989-04-17
Publication date
1990-11-05
1989-04-17
Application filed by Vespa Laboratories Inc
filed
Critical
Vespa Laboratories Inc
1990-11-05
Publication of AU3577589A
publication
Critical
patent/AU3577589A/en
1993-09-02
Application granted
granted
Critical
1993-09-02
Publication of AU640611B2
publication
Critical
patent/AU640611B2/en
2009-04-17
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K38/00—Medicinal preparations containing peptides
A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
A61K31/425—Thiazoles
A61K31/429—Thiazoles condensed with heterocyclic ring systems
A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/70—Carbohydrates; Sugars; Derivatives thereof
A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K38/00—Medicinal preparations containing peptides
A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 – A61K41/00
A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/04—Antibacterial agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/12—Antivirals
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P35/00—Antineoplastic agents
AU35775/89A
1989-04-13
1989-04-17
Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
Ceased
AU640611B2
(en)
Applications Claiming Priority (3)
Application Number
Priority Date
Filing Date
Title
US33609689A
1989-04-13
1989-04-13
US336096
1989-04-13
CA000596851A
CA1337330C
(en)
1989-04-13
1989-04-17
Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
Publications (2)
Publication Number
Publication Date
AU3577589A
true
AU3577589A
(en)
1990-11-05
AU640611B2
AU640611B2
(en)
1993-09-02
Family
ID=25672623
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU35775/89A
Ceased
AU640611B2
(en)
1989-04-13
1989-04-17
Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
Country Status (5)
Country
Link
EP
(1)
EP0419501B1
(en)
JP
(1)
JP2809458B2
(en)
AU
(1)
AU640611B2
(en)
CA
(1)
CA1337330C
(en)
WO
(1)
WO1990011766A1
(en)
Families Citing this family (3)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
DK82892D0
(en)
*
1992-06-24
1992-06-24
Michael Hansen
APPLICATION OF BRAIN ADDITION FROM BEES AND WHEPS FOR THE PREPARATION OF MEDICINAL PRODUCTS TO TREAT INFECTIONS
KR101099550B1
(en)
*
2009-04-02
2011-12-28
대한민국
Composition of comprising bee-venoms for treating wounds or burns
KR101018352B1
(en)
*
2009-07-28
2011-03-04
동성제약주식회사
Composition of comprising bee-venoms for treating acne
Family Cites Families (3)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
JPS55149214A
(en)
*
1979-05-10
1980-11-20
Toyama Chem Co Ltd
Medical composition consisting of extract from liquid in bee poison gland
EP0299828B1
(en)
*
1987-07-01
1994-06-15
Plant Genetic Systems N.V.
Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications
US4822608A
(en)
*
1987-09-14
1989-04-18
Vespa Laboratories, Inc.
Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom or proteinaceous or polypeptide components thereof
1989
1989-04-17
WO
PCT/US1989/001643
patent/WO1990011766A1/en
active
IP Right Grant
1989-04-17
AU
AU35775/89A
patent/AU640611B2/en
not_active
Ceased
1989-04-17
JP
JP1505858A
patent/JP2809458B2/en
not_active
Expired – Fee Related
1989-04-17
CA
CA000596851A
patent/CA1337330C/en
not_active
Expired – Fee Related
1989-04-17
EP
EP89905941A
patent/EP0419501B1/en
not_active
Expired – Lifetime
Also Published As
Publication number
Publication date
EP0419501B1
(en)
1993-03-03
JPH03505449A
(en)
1991-11-28
CA1337330C
(en)
1995-10-17
JP2809458B2
(en)
1998-10-08
EP0419501A1
(en)
1991-04-03
AU640611B2
(en)
1993-09-02
WO1990011766A1
(en)
1990-10-18
Similar Documents
Publication
Publication Date
Title
AU4205789A
(en)
1990-04-02
Method and composition for the treatment and prevention of viral infections
AU4403689A
(en)
1990-05-01
Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
HUT46365A
(en)
1988-10-28
Process for producing glycopeptide antibiotics and pharmaceutical compositions comprising the same
AU2724088A
(en)
1989-04-18
Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
IT1221776B
(en)
1990-07-12
PROCESS FOR THE PREPARATION OF 1,2 DIFLUOROETHANE AND 1,1,2 TRIFLUOROETHANE
AU5048090A
(en)
1990-08-24
Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasm in human body, and the cloning of full length cdna thereof
AU3101689A
(en)
1989-09-14
Process for the preparation of cyclic sulphates
AU2157888A
(en)
1989-06-08
Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
IT8719165D0
(en)
1987-01-26
DERIVED FROM THIAZOLIDIN-4-CARBOXYLIC ACID, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
AU2923389A
(en)
1989-08-11
A pharmaceutical composition
AU7635887A
(en)
1988-02-04
Recombinant HTLV-III proteins and uses thereof
AU2192588A
(en)
1989-03-09
Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production
AU6920387A
(en)
1987-09-03
Molecular probes, process for preparation thereof, and applications including their use for determining the sex of embryos
CA2138793A1
(en)
1994-01-06
Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections
AU3577589A
(en)
1990-11-05
Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
AU2845989A
(en)
1989-08-03
Use of milk proteins for the manufacture of an anti-viral medicament
AU6660090A
(en)
1991-08-01
Treatment of depression
AU7515287A
(en)
1988-01-11
Methods and compositions for treating viral infections
IL95711A0
(en)
1991-06-30
Anticoagulant and anthelmintic proteins and methods for the production and use of the same
EP0362162A3
(en)
1990-05-30
Pharmaceutical composition comprising zidovudine and inosiplex or components thereof for the treatment of aids and aids-related syndromes
AU6406590A
(en)
1991-04-28
Porcine lactoferrin amino acid and cdna sequence
AU2117388A
(en)
1989-04-27
Recombinant htlv-iii proteins and uses thereof
AU6527390A
(en)
1991-06-26
Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
AU4829190A
(en)
1990-07-10
Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
AU6600190A
(en)
1991-04-18
Therapeutic compositions; methods for treatment of hiv infections
None